Aralez Pharmaceuticals Inc. (ARZ) Stock Price Up -2%
Aralez Pharmaceuticals Inc. (TSE:ARZ) rose 2% during trading on Thursday . The company traded as high as C$2.07 and last traded at C$2.00. Approximately 44,902 shares changed hands during trading, an increase of 6% from the average daily volume of 42,403 shares. The stock had previously closed at C$2.04.
TRADEMARK VIOLATION NOTICE: “Aralez Pharmaceuticals Inc. (ARZ) Stock Price Up -2%” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/11/16/aralez-pharmaceuticals-inc-arz-stock-price-up-2.html.
About Aralez Pharmaceuticals
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Stock Ratings for Aralez Pharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals Inc. and related stocks with our FREE daily email newsletter.